Author Archives: Natalie Themm
Canary Speech Earns Microsoft Solutions Partner: Healthcare AI Certified Software Designation
Prestigious recognition validates Canary Speech’s leadership in healthcare-focused AI voice technology and its proven interoperability with the Microsoft Cloud
bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia
bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia
PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers
PolarityBio thanks the clinical trial sites and, most importantly, the participants, for making this milestone in DFU biologic therapy development possible
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
Milestone enables immediate production of SiN/PEEK custom devices
5 Trends to Expect From Vocal Biomarker Technology in 2026
By Henry O’Connell, CEO and co-founder of Canary Speech Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the human voice to assist in diagnoses is established fact. Providers already possess technological platforms that make informed care […]
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
100% of genes strongly recommended by national oncology guidelines are included in the MyRisk Test.
New Preclinical Study Demonstrates Feasibility of Microbubble-Mediated, Non-Thermal Focused Ultrasound for Brain Tumor Ablation
Salt Lake City, UT –Wednesday November, 5th 2025— Researchers from the University of Utah and Microvascular Therapeutics (MVT) will be presenting new preclinical data demonstrating that focused ultrasound (FUS) using proprietary phase-shift microbubbles, NanoBlate (MVT-101), can selectively ablate brain tumors and open the blood-brain barrier (BBB) in targeted regions, potentially enabling safer, more precise, and […]
Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs
Collaboration bridges home and hospital, creating a secure pathway for pediatric insights to be managed and shared.
J3 Bioscience Announces Collaboration to Study LIV-Ring VR101 for Cancer-Therapy–Related Vaginal Dryness
Investigator-Initiated, grant-supported pilot study evaluating a novel non-prescription therapy for cancer-related vaginal dryness.
2025 BioUtah Life Sciences Awards Presented at the Mayer Brown Utah Life Sciences Summit
BioUtah will honor outstanding leaders in Utah’s life sciences community with five awards recognizing contributions to the industry.
PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial
PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty (PTA) through 24 months
